• Healius (ASX:HLS) share price pushes higher on solid Q3 update

    woman in lab coat conducting testing representing mesoblast share price

    The Healius Ltd (ASX: HLS) share price is edging higher on Wednesday morning following the release of a trading update.

    In early trade, the healthcare company’s shares are up 0.5% to $4.10.

    How is Healius performing in FY 2021?

    According to the release, Healius delivered a strong trading performance in the third quarter of FY 2021. Though, it does acknowledge that it was cycling weaker comparative data late in the period.

    In respect to its Pathology business, Healius reported that COVID testing continues, with the company recently reaching 3 million COVID tests in total. This includes over 800,000 tests undertaken in the third quarter, which was on par with its first half levels.

    Management advised that this includes a growing amount of commercial COVID testing.

    Positively, non-COVID Pathology revenue was solid during the third quarter. This led to 5% growth compared to the prior corresponding period. It was also higher than first half levels. A positive test mix has been supporting higher average fees.

    The company’s Imaging business performed positively during the third quarter. Healius reported an 8% increase in revenue compared to the prior corresponding period.

    Management notes that it has experienced different recovery rates in different states, with Victoria showing a progressive recovery.

    Finally, its Day Hospitals business was a particularly positive performer during the third quarter. It reported a 25% increase in revenue over the prior corresponding period. This was driven largely by its Montserrat hospital.

    The company also advised that its Westside Private Hospital performed nearly 1,000 procedures in March, its best month to-date. It also successfully completed its first hip and knee replacements.

    Another positive was that its Adora Fertility continued to trade profitably. Though, management revealed that it is exploring potential sale options for the IVF business. These options are in the preliminary stages and no decision has yet been made.

    The Healius share price is now up 67% over the last 12 months.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Healius (ASX:HLS) share price pushes higher on solid Q3 update appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3h2nFiE

  • City Chic (ASX:CCX) share price on watch on trading update

    asx retail shares represented by woman carrying shopping bags riding up escalator

    The City Chic Collective Ltd (ASX: CCX) share price is on watch today after the retail business revealed a trading update.

    What does City Chic do?

    City Chic is a global apparel, footwear and accessories retailer for plus-size women. It has an established footprint in Australia, New Zealand and the US. It also recently entered the UK with the acquisition of Evans.

    The company gave a presentation about its business and the current trading conditions.

    In the 12 months to December 2020, it generated $209 million of global sales. Around 73% of those sales were online, up from 36% in FY18. It had 801,000 active customers at December 2020 and 42 million global online traffic visits over the 12 months to December 2020.

    For the 2020 calendar year, 45% of sales were made in the northern hemisphere, up from 16% of sales in FY18.

    Plus-size market growth

    City Chic said that the plus-size market is forecast to grow by 7% annually. The average annual spend in plus-size is currently materially less than the rest of the women’s apparel market. The retailer pointed out that there is an increasing rate of plus-size women globally.

    The ASX share was pleased that plus-size women have embraced shopping online. Current online sales represent 25% of total plus-size sales globally, so there’s still plenty of growth potential there. City Chic said there’s strong forecast growth in online channels in the global plus-size market, which is where City Chic is focused.

    City Chic sees long-term growth potential

    The retailer said there’s significant market share opportunity in the US$49 billion market. Cross-selling of City Chic products to Avenue customers is tracking very well. To capture this US opportunity, it’s expanding its marketing campaigns to grow its customer base and re-engage customers. City Chic is also expanding its existing marketplace partnerships and entering new ones.

    In the UK there’s a market share opportunity in the US$7 billion market. The Evans acquisition accelerates this entry.

    City Chic is targeting a market entry for ‘conservative value’ in Australia and New Zealand. The website development is underway, targeting a launch in the first half of FY22. It’s leveraging the product stream already designed for Avenue and Evans, whilst leveraging the existing infrastructure.

    A market entry into Europe is the final part of the initiative to lead a world of curves. There’s a “significant” market share opportunity in the US$45 billion market. City Chic is currently trialling in Europe with its wholesale channel. The partner marketplace strategy in Europe is well-progressed with the launch expected in the first half of FY22.

    Trading update

    There has been “strong” positive comparable sales growth and strong customer base growth in the second half of FY21 to date. May and June are typically large trading months, so they are important.

    The gross profit margin for all channels has now fully recovered since the higher levels of discounting in early and mid 2020 due to COVID-19.

    It’s going to continue to invest in inventory to drive online growth globally as well as its partner business.

    ANZ sales are strong. City Chic US website sales are now back to growth, driven by a strong rebound in the dress category in March 2021. Avenue.com is trading well with strong growth. US partner channel sales are still down due to COVID-19, however sales have been recovering. Evans has been fully integrated ahead of schedule and under budget, the COVID lockdowns and restrictions in the UK started to ease from April 2021.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post City Chic (ASX:CCX) share price on watch on trading update appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3tkKXm4

  • ASX 200 tech shares under pressure after Nasdaq selloff

    nervous looking asx investor holding hands to her face

    The Nasdaq found itself in deep waters on Tuesday as steep declines in mega cap shares pushed the index as much as 3% lower.

    Bouncing off intraday lows, the index managed to close 1.88% down for the day. However, the negative sentiment has carried over to ASX 200 tech shares today. 

    Why ASX 200 tech shares are coming under pressure 

    High profile United States tech companies including Facebook Inc (NASDAQ: FB)Apple Inc (NASDAQ: AAPL)Amazon.com Inc (NASDAQ: AMZN), and Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) all fell between 1.3% to 3.5%. 

    Another US-listed tech stock to note is Affirm Holdings Inc (NASDAQ: AFRM) which dived 6.9% lower. The Affirm share price has shed 16% in value in this week alone to set a new all-time record low.

    Conversely, cyclical and defensive sectors such as banks, consumer staples, and real estate outperformed and finished near positive territory, helping the Dow Jones Industrial Average Index (DJX: .DJI) to close 0.06% higher. 

    This seems to be spelling bad news for the likes of ASX 200 tech shares like Afterpay Ltd (ASX: APT) and Zip Co Ltd (ASX: Z1P) as well as fellow buy now, pay later stablemate Sezzle Inc (ASX: SZL).

    At the time of writing, the Afterpay share price is trading 2.88% lower at $107.38. Zip shares are also down 2.74%, trading at $7.45. Meanwhile, the Sezzle share price has fallen a painful 4.33% to $8.61.   

    Why are tech shares selling off? 

    Today’s selloff arguably continues to reinforce the recent rotation out of tech-related sectors, and back into cyclical sectors and value shares. Many stocks that outperformed during the pandemic are suddenly on the back foot as the real economy continues to recover. 

    A recent example of this can be seen in the selloff of ASX e-commerce shares such as Kogan.com Ltd (ASX: KGN) and Redbubble Ltd (ASX: RBL).

    Why it’s not all doom and gloom 

    Despite the weakness in tech, the ASX 200 is heavily weighted towards financials. The US financials sector managed to close 0.7% higher while other notable sectors such as materials and industrials closed a respective 1.04% and 0.41% higher. At the time of writing, three of the big four ASX 200 banks are trading in the green.

    If the ASX 200 were to follow in the footsteps of the US market today, the selling pressure could continue to be concentrated in tech and growth-related sectors. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool’s board of directors. Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Alphabet (A shares), Alphabet (C shares), Amazon, Apple, and Facebook. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and ZIPCOLTD FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Sezzle Inc and recommends the following options: long January 2022 $1920 calls on Amazon, short March 2023 $130 calls on Apple, short January 2022 $1940 calls on Amazon, and long March 2023 $120 calls on Apple. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Alphabet (A shares), Alphabet (C shares), Amazon, Apple, Facebook, Kogan.com ltd, and Sezzle Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX 200 tech shares under pressure after Nasdaq selloff appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3b1FmLs

  • Is it time to give the A2 Milk (ASX:A2M) share price another chance?

    Glass of milk

    The discounted A2 Milk Company Ltd (ASX: A2M) share price has likely tempted many investors to buy the ex-market darling.

    The A2 Milk share price has made a small bounce since last week. However, this change has come without any major changes or announcements from the company. Could this be another so-called ‘dead cat bounce’? 

    UBS slaps a buy rating on the A2 Milk share price

    UBS has come forth with a bold buy rating for A2 Milk shares on Wednesday. A meaningful recovery in daigou infant formula sales over the next two years and substantial market share gains in China underpins its buy recommendation. 

    Despite a positive medium-term view, the broker lowered its net profit estimates by 4-12% for FY21-23. This is due to slower sales recovery and greater short-term pressures in margins. Its target price was also reduced from NZ$16 ($14.86) to NZ$15.50 ($14.39). 

    Other brokers say otherwise 

    Brokers are divided for where the A2 Milk share price will go next. In the case of Citi and Credit Suisse, both brokers were a respective sell and underperform rated on A2 shares with a $7.15 target price. 

    After conducting a survey, Citi’s US retail team observed that consumers in China are currently more likely to buy domestic athletic brands compared to foreign athletic brands such as Nike and Adidas. The broker believes this trend is consistent in other consumer-related categories including infant formula and vitamins. 

    Credit Suisse’s commentary highlights the decline in birth rates. Furthermore, it is expected that babies of infant formula age will be around 30% lower in 2025 compared with 2018. The broker believes this could undermine the anticipated recovery for A2 Milk. 

    Big shareholders continue to sell A2 Milk 

    On 23 April, the Commonwealth Bank of Australia (ASX: CBA) announced that it had reduced its stake in A2 Milk from 46.9 million shares, or 6.34% of the company, to 39.5 million shares, or 5.32%. 

    Five days later, CBA disposed of another 2.5 million shares, reducing its holding to 37 million shares, equivalent to 4.97% of the company. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Is it time to give the A2 Milk (ASX:A2M) share price another chance? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3toqJYB

  • Advanced Human Imaging (ASX:AHI) share price sinks despite positive update

    falling asx share price represented by child looking shocked at computer screen

    The Advanced Human Imaging Ltd (ASX: AHI) share price is in negative territory during early morning trade today. This comes despite the company announcing it has teamed up with Discovery subsidiary Vitality to start a CompleteScan pilot program.

    At the time of writing, the Advanced Human Imaging share price has plummeted 4.6% to $1.55 apiece.

    Commercial opportunity for CompleteScan

    In today’s release, the human scanning technology provider advised it will partner with Vitality for a larger consumer-facing pilot of its CompleteScan app.

    Established in 1992, Discovery is a South African financial services company that operates in the healthcare, life assurance, savings and investment, and wellness markets. Its Vitality business is one of the world’s leading behavioural change platforms that rewards member for adopting a healthy lifestyle. The shared-value insurance model spans 28 countries and has more than 20 million members.

    The partnership follows a collaboration by both parties over the last 12 months in testing Advanced Human Imaging technology.

    The CompleteScan pilot program will be adopted by onsite wellness specialists across 4 Discovery facilities in South Africa.

    Advanced Human Imaging stated that the pilot’s primary objective was to demonstrate the real-time data accuracy and efficiencies of the CompleteScan system.

    Throughout this month, onsite wellness specialists will compare health evaluations of participants against the accuracy of results when using CompleteScan.

    Advanced Human Imaging and Discovery Vitality are currently in discussions about the commercial prospect for ongoing access to CompleteScan.

    Management commentary

    Advanced Human Imaging CEO Vlado Bosanac welcomed the pilot program, saying:

    Discovery’s behavioural change platform ‘Vitality’ sets the benchmark for health engagement and rewards. Discovery in my view were the pioneers of rewards based incentivised health outcome and have a proven track record of success.

    The CompleteScan integration will deliver a high-quality cost-effective data set, which will have exponential value in risk assessment and management when integrated into a solution like Vitality.

    Better health outcomes mean better quality of life. The ethos of a platform of this nature is to do exactly that, help people live better healthier lives. This is where the CompleteScan application is most effective, by identifying negative health indicators through actionable data for early intervention.

    About the Advanced Human Imaging share price

    Over the last 12 months, Advanced Human Imaging shares have accelerated to post a gain of more than 800%. Year-to-date performance stands at around 30% higher than the beginning of 2021.

    Advanced Human Imaging has a market capitalisation of roughly $220 million, with approximately 136.3 million shares on issue.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Advanced Human Imaging (ASX:AHI) share price sinks despite positive update appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3egapoy

  • Is the Flight Centre (ASX:FLT) share price a buy after its Q3 update?

    asx airport shares represented by plane and luggage next to large question mark

    The Flight Centre Travel Group Ltd (ASX: FLT) share price was out of form on Tuesday and sank almost 5% following the release of a third quarter update.

    Things haven’t been any better today, with the travel agent’s shares down 4% to $15.53 in early trade.

    What happened in the third quarter?

    According to the release, after a subdued sales period in January and February, Flight Centre achieved record COVID-period sales revenue during the month of March.

    It advised that March turnover was more than $100 million higher than February, up 32.7% month-on-month. This took gross quarterly total transaction value (TTV) back above $1 billion for first time since COVID-19.

    However, despite this improvement, Flight Centre is still operating at a loss.

    As a result, it is expecting its second half underlying loss to be broadly in line with its first half loss in FY 2021. This appeared to disappoint the market, weighing on the Flight Centre share price.

    What was the reaction to this?

    Brokers have been giving their opinion on this update today and the reaction has been mixed.

    Analysts at Macquarie Group Ltd (ASX: MQG) remain positive on the company and have retained their outperform rating. However, the broker has cut its price target by 12.5% to $17.50.

    Macquarie believes that Flight Centre’s valuation is supported by strong macro conditions and the expected shift in its sales mix towards the corporate market. It also notes that a recovery in domestic travel is already underway and the recent Australia-New Zealand travel bubble suggests there could be a gradual recovery in international travel.

    Citi has responded to the update by upgrading its recommendation to neutral with a price target of $17.30. It notes that Flight Centre’s earnings outlook remains highly uncertain and isn’t expecting the company to breakeven until FY 2023.

    Remaining bearish is Morgan Stanley. Its analysts have retained their underweight rating and cut their price target by 8.5% to $16.00. It has concerns over its valuation and notes that its recovery profile is uncertain.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Is the Flight Centre (ASX:FLT) share price a buy after its Q3 update? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3tdVEa8

  • PointsBet (ASX:PBH) share price slumps despite US iGaming launch

    gambling asx share price fall represented by woman in soccer had looking frustrated at tablet screen

    PointsBet Holdings Ltd (ASX: PBH) shares are inching lower in early trade despite the company announcing its iGaming platform has launched in Michigan. At the time of writing, the PointsBet share price is trading 0.14% lower at $14.03. 

    Let’s take a closer look at the news from the online bookmaker this morning.

    PointsBet’s iGaming outlook

    The PointsBet share price is failing to respond following news the company’s subsidiary, PointsBet Michigan LLC, has launched its iGaming platform in the state. This came after PointsBet received authorisation from the Michigan Gaming Control Board. 

    iGaming is the act of betting on the outcome of an event – typically sports events – online.  

    PointsBet has ongoing and upcoming iGaming markets in New Jersey, Pennsylvania, Michigan, and West Virginia.

    According to PointBet’s release, the combined iGaming revenues from the 4 states in the quarter ended 31 March 2021 was US$770 million. If consistent, revenue from the states will equate to $3 billion annually.  

    PointsBet launched its sports wagering product in Michigan in January. It plans to launch its iGaming platform in New Jersey in June.

    The company states that New Jersey’s iGaming industry had a compound annual growth rate of 25% between 2014 and 2018. It also said iGaming revenues from the state grew by 101% last year.

    According to PointsBet, profits from iGaming in the United States have increased dramatically over the last 3 years due to the repealing of the Professional and Amateur Sports Act. The Act effectively banned sports betting throughout most of the United States.

    Commentary from management

    PointsBet’s group CEO and managing director Sam Swanell commented on the news, saying:

    Over the past 18 months we have assembled a highly experienced iGaming team which has built our in-house proprietary iGaming platform and administrative tools and I am thrilled today to announce the inaugural launch in Michigan.

    The launch of iGaming not only complements our existing sports wagering products, but also removes the disadvantage we have had with customer acquisition, retention and cross sell compared to those operators with iGaming.

    PointBet share price snapshot

    Despite today’s disappointing reaction, the PointsBet share price has been performing well on the ASX lately. Currently, the company’s shares are up by almost 19% year to date. They are also up by a whopping 235% over the last 12 months.

    PointsBet has a market capitalisation of around $2.6 billion, with approximately 207 million shares outstanding.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pointsbet Holdings Ltd. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post PointsBet (ASX:PBH) share price slumps despite US iGaming launch appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/33t66Al

  • Here’s How Warren Buffett Explained Berkshire Hathaway’s Bank Selloff

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Warren Buffett

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Berkshire Hathaway‘s (NYSE: BRK.A) (NYSE: BRK.B) annual shareholder meeting and its marathon question-and-answer session have once again come and gone, offering investors another glimpse into the extraordinary mind of legendary investor Warren Buffett. Some of the questions that came up in Saturday’s livestream dealt with moves Berkshire made during the early stages of the pandemic last year — including what led the company to exit most of its banking positions while loading up on Bank of America (NYSE: BAC). After months of speculation, Buffett gave a little bit of insight into what drove his decision making.

    Too much exposure

    Prior to the pandemic, Berkshire owned a slate of bank stocks, and Buffett seemed to have a bullish stance toward the sector. However, as stay-at-home orders and economic shutdowns spread across the country and banks braced for heavy loan losses, Buffett seemed to do a 180 and exited many of his holdings.

    Berkshire eliminated its stake in investment bank Goldman Sachs and eventually JPMorgan Chase, America’s largest bank by assets. Berkshire also sold its position in regional banks like PNC Financial Services Group and M&T Bank. And Buffett appears to be looking for an exit on former favorite Wells Fargo, selling shares gradually for the past several quarters.

    While all of this was going on, Buffett and Berkshire pumped more than $2 billion of stock into Bank of America and increased the company’s stake to 11.9% of outstanding shares, a move that required special regulatory approval.

    While we don’t yet know what moves Buffett has made in 2021, he doesn’t appear to have done much, since the cost basis of Berkshire’s bank, insurance, and finance stocks after the first quarter was just slightly higher than it was at the end of 2020.

    During the Q&A part of Berkshire’s shareholder meeting, Buffett was asked why he had sold most of his bank stocks last year.

    “I like banks generally, I just didn’t like the proportion we had compared to the possible risk if we got the bad results that so far we haven’t gotten,” Buffett said. “We overall didn’t want as much in banks as we had.”

    The Oracle of Omaha added: “The banking business is way better than it was in the United States 10 or 15 years ago. The banking business around the world — in various places — might worry me. But our banks are in far, far better shape than 10 or 15 years ago. But when things froze for a short period of time, the biggest thing the banks had going for them was that the Federal Reserve was behind them, and the Federal Reserve is not behind Berkshire. It’s up to us take care of ourselves.”

    What to make of this

    Buffett is one of the greatest investing minds of all time, if not No. 1, so it’s important to realize that it will be difficult for us to see these moves exactly as he does. And I can certainly appreciate his remark about having too much exposure. Keep in mind, Buffett is managing an equities portfolio of hundreds of billions of dollars, so a few percentage points one way or the other is huge. He needs to think about safety much more than your standard responsible investor (Buffett sometimes refers to himself as Berkshire’s “chief risk officer,” and he did so again on Saturday). But it really is difficult for me to understand all these moves.

    Goldman Sachs is not very loan-heavy, so it didn’t really face the same degree of risk as other large banks like Bank of America and JPMorgan Chase. Investment banks also tend to do better in periods of volatility, and Goldman is working to build up its consumer bank and asset and wealth management divisions to generate steadier revenues. Goldman’s stock is nearly 40% higher than it was prior to the pandemic, and many think it’s still trading cheap.

    Buffett’s decision to load up on Bank of America and dump JPMorgan as an even bigger mystery to me. JPMorgan not only has a more diversified business, but its earnings power is greater, as well. The bank is also extremely safe. Its reserves for loan losses peaked at $34 billion during 2020, but the bank was prepared for scenarios where its reserves would have peaked at $52 billion. JPMorgan also engineered its way through the Great Recession better than any of the largest banks in America. Buffett officially eliminated Berkshire’s stake in JPMorgan in the fourth quarter of the year. Meanwhile, the stock is up nearly 21% year to date at Tuesday’s prices, and Buffett likely missed out on even more appreciation, considering he sold the bulk of his JPMorgan position in the third quarter of 2020.

    Hindsight is, of course, 20/20, but the numbers are also the numbers, and Buffett missed out on huge gains on his former bank holdings that could just be getting started. Banks are potentially poised for a strong multiyear run, with earnings expected to jump in a rising-rate environment. Buffett did say Saturday that he is concerned about “very substantial inflation,” so maybe he thinks too much inflation may kill loan demand, or that rising rates might reveal bad credit quality. However, cyclical stocks like banks and financials tend to perform better during inflation than high-growth tech stocks, which Berkshire has recently made a bigger part of its portfolio than financials.

    Is Buffett done with banking?

    Buffett has not abandoned the sector altogether. Bank of America is still Berkshire’s second-largest holding behind Apple. Berkshire also still has large positions in American ExpressU.S. Bancorp, and Bank of New York Mellon. Buffett also may not be pulling all the strings here — he’s ceded a lot of Berkshire’s investing authority to others who may be making the decisions. It has long been known that two of Buffett’s lieutenants, Todd Combs and Ted Weschler, are much more involved in Berkshire’s portfolio decisions now. In addition, Berkshire recently confirmed that Berkshire’s Vice Chairman Greg Abel is expected to succeed Buffett as CEO when he eventually steps aside.

    But with all that has recently happened, it does seem like it could be a while until we see Berkshire buy traditional bank stocks again.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Bram Berkowitz has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple and Berkshire Hathaway (B shares) and recommends the following options: short January 2023 $200 puts on Berkshire Hathaway (B shares), short March 2023 $130 calls on Apple, short June 2021 $240 calls on Berkshire Hathaway (B shares), long March 2023 $120 calls on Apple, and long January 2023 $200 calls on Berkshire Hathaway (B shares). The Motley Fool Australia has recommended Apple and Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Here’s How Warren Buffett Explained Berkshire Hathaway’s Bank Selloff appeared first on The Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from The Motley Fool Australia https://ift.tt/33e2nGm

  • Why the MoneyMe (ASX:MME) share price is charging 6% higher today

    unstoppable asx share price represented by man in superman cape pointing skyward

    The MoneyMe Ltd (ASX: MME) share price has been a strong performer on Wednesday.

    At the time of writing, the digital credit company’s shares are up 6% to $1.43.

    This has reduced the year to date decline by the MoneyMe share price to just 2.5%.

    Why is the MoneyMe share price charging higher?

    Investors have been buying MoneyMe shares following the release of an update this morning.

    Pleasingly, that update was positive enough to offset broad weakness in the tech sector following a selloff on Wall Street’s Nasdaq index overnight.

    According to the release, MoneyMe was on form again during the month of April and delivered record originations of $47 million for the month. This is up 693% over the prior corresponding period.

    Management advised that the strong performance in originations was achieved through existing products, excluding its recently launched Autopay innovation.

    In light of this, the company has revised its expectations for gross customer receivables to exceed $300 million in FY 2021. This will be up at least 225% year on year from $134 million in FY 2020.

    This is expected to lead to overall revenue coming in at $58 million to $62 million in FY 2021.

    Management commentary

    MoneyMe’s Managing Director and CEO, Clayton Howes, was pleased with the company’s performance in April.

    He said: “We are pleased to report the strong growth and momentum in MoneyMe. Record originations in April are a direct result of our products continuing to deliver amazing customer experiences, including from automated on-the-spot decisioning and fast settlement geared to the needs of Gen Now.”

    “We have a strong product pipeline to support revenue growth. Our lastest product, the recently launched Autopay, is a same day drive away finance innovation we expect to materially add to the growth of MoneyMe. Launched on the 21st of April, Autopay is already transacting sales in dealerships,” he concluded.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the MoneyMe (ASX:MME) share price is charging 6% higher today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3uoeNHY

  • Is the CSL (ASX:CSL) share price in the buy zone after its update?

    A doctor looks unsure, indicating share price uncertainty for ASX medical companies

    The CSL Limited (ASX: CSL) share price is on the move on Wednesday morning.

    At the time of writing, the biotherapeutics giant’s shares are up 1.5% to $275.25.

    Why is the CSL share price on the move today?

    This morning the biotherapeutics company released a presentation ahead of its appearance at the Macquarie Group Ltd (ASX: MQG) conference.

    While the presentation didn’t include a trading update for the third quarter of FY 2021, it did provide more colour on its plasma collections.

    Plasma is a vital part of the process in the manufacturing of many of its therapies.

    Over the last 12 months plasma collections have been under pressure due to COVID-19 related headwinds such as social distancing, lower mobility, and stimulus payments. The latter has reduced the need for some donors to make donations for an extra source of income.

    What is the latest?

    Management acknowledged that plasma collections have been adversely impact and additional collection costs have been incurred.

    However, it has been mitigating this with a comprehensive campaign to raise awareness of the opportunity and need for plasma donation. Importantly, all its centres have remained open during the pandemic after being designated as essential critical infrastructure.

    CSL has also continued to expand its footprint, with 25 new centres opening in the United States in the current financial year. This brings its network to over 300 cents, with the vast majority (284) in the United States market.

    Pleasingly, management isn’t resting on its laurels and intends to open a further 40 new centres in FY 2022.

    Incidentally, a recent note out of Citi reveals that its analysts believe plasma collections will return to 2019 levels in the second half of 2021. If this proves accurate, CSL will be well-positioned to benefit thanks to its expanding network.

    Is the CSL share price in the buy zone?

    According to the aforementioned note out of Citi from late last month, the CSL share price is good value at present.

    Citi currently has a buy rating and $310.00 price target on the company’s shares.

    Based on the current CSL share price, this price target implies potential upside of 12.5% over the next 12 months.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Is the CSL (ASX:CSL) share price in the buy zone after its update? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3uktb3Q